Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamás Biernacki

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cells|July 2, 2020
Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic PerspectivesTamás Biernacki, Dániel Sandi, Krisztina Bencsik, et al.
Ideggyogyaszati Szemle|June 6, 2018
[Alemtuzumab therapy 2017]Tamás Biernacki, Krisztina Bencsik, Dániel Sandi, et al.
Mini Reviews in Medicinal Chemistry|October 24, 2019
Medicinal Chemistry of Multiple Sclerosis: Focus on CladribineTamás Biernacki, Dániel Sandi, Krisztina Bencsik, et al.
International Journal of Molecular Sciences|May 14, 2022
Proteomics in Multiple Sclerosis: The Perspective of the ClinicianDániel Sandi, Zsófia Kokas, Tamás Biernacki, et al.
Ideggyogyaszati Szemle|June 6, 2018
[The Multiple Sclerosis Registry of Szeged]Krisztina Bencsik, Dániel Sandi, Tamás Biernacki, et al.
Ideggyogyaszati Szemle|June 6, 2018
[Change of therapeutic algorithm in sclerosis multiplex based on two case reports]Tamás Biernacki, Krisztina Bencsik, Zsigmond Tamás Kincses, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 8, 2018
Pediatric multiple sclerosis and fulminant disease course: Features and approaches to treatment - A case report and review of the literatureDániel Sandi, Edit Bereg, Tamás Biernacki, et al.
Brain and Behavior|November 12, 2019
Contributing factors to health-related quality of life in multiple sclerosisTamás Biernacki, Dániel Sandi, Zsigmond Tamás Kincses, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 22, 2024
Fatigue and depression influence the prevalence of anxiety in patients with multiple sclerosisAliz Nyári, Zsófia Kokas, Szabolcs Szamosi, et al.
Brain and Behavior|March 21, 2020
Epidemiology of multiple sclerosis in Central Europe, update from HungaryTamás Biernacki, Dániel Sandi, Zsanett Fricska-Nagy, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cells|July 2, 2020
Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic PerspectivesTamás Biernacki, Dániel Sandi, Krisztina Bencsik, et al.
Ideggyogyaszati Szemle|June 6, 2018
[Alemtuzumab therapy 2017]Tamás Biernacki, Krisztina Bencsik, Dániel Sandi, et al.
Mini Reviews in Medicinal Chemistry|October 24, 2019
Medicinal Chemistry of Multiple Sclerosis: Focus on CladribineTamás Biernacki, Dániel Sandi, Krisztina Bencsik, et al.
International Journal of Molecular Sciences|May 14, 2022
Proteomics in Multiple Sclerosis: The Perspective of the ClinicianDániel Sandi, Zsófia Kokas, Tamás Biernacki, et al.
Ideggyogyaszati Szemle|June 6, 2018
[The Multiple Sclerosis Registry of Szeged]Krisztina Bencsik, Dániel Sandi, Tamás Biernacki, et al.
Ideggyogyaszati Szemle|June 6, 2018
[Change of therapeutic algorithm in sclerosis multiplex based on two case reports]Tamás Biernacki, Krisztina Bencsik, Zsigmond Tamás Kincses, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|May 8, 2018
Pediatric multiple sclerosis and fulminant disease course: Features and approaches to treatment - A case report and review of the literatureDániel Sandi, Edit Bereg, Tamás Biernacki, et al.
Brain and Behavior|November 12, 2019
Contributing factors to health-related quality of life in multiple sclerosisTamás Biernacki, Dániel Sandi, Zsigmond Tamás Kincses, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 22, 2024
Fatigue and depression influence the prevalence of anxiety in patients with multiple sclerosisAliz Nyári, Zsófia Kokas, Szabolcs Szamosi, et al.
Brain and Behavior|March 21, 2020
Epidemiology of multiple sclerosis in Central Europe, update from HungaryTamás Biernacki, Dániel Sandi, Zsanett Fricska-Nagy, et al.
Pageof 2